DE3480764D1 - Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen. - Google Patents

Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.

Info

Publication number
DE3480764D1
DE3480764D1 DE8484104705T DE3480764T DE3480764D1 DE 3480764 D1 DE3480764 D1 DE 3480764D1 DE 8484104705 T DE8484104705 T DE 8484104705T DE 3480764 T DE3480764 T DE 3480764T DE 3480764 D1 DE3480764 D1 DE 3480764D1
Authority
DE
Germany
Prior art keywords
treatment
fishing
pharmaceutical compositions
useful pharmaceutical
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484104705T
Other languages
German (de)
English (en)
Inventor
Nikolaus Seiler
Shakir Sarhan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3480764D1 publication Critical patent/DE3480764D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8484104705T 1983-04-29 1984-04-26 Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen. Expired - Lifetime DE3480764D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838311804A GB8311804D0 (en) 1983-04-29 1983-04-29 Treatment of seizure disorders and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
DE3480764D1 true DE3480764D1 (de) 1990-01-25

Family

ID=10541938

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484104705T Expired - Lifetime DE3480764D1 (de) 1983-04-29 1984-04-26 Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.

Country Status (15)

Country Link
US (1) US4540582A (cg-RX-API-DMAC10.html)
EP (1) EP0124091B1 (cg-RX-API-DMAC10.html)
JP (1) JPS59206309A (cg-RX-API-DMAC10.html)
AT (1) ATE48759T1 (cg-RX-API-DMAC10.html)
AU (1) AU563291B2 (cg-RX-API-DMAC10.html)
CA (1) CA1228818A (cg-RX-API-DMAC10.html)
DE (1) DE3480764D1 (cg-RX-API-DMAC10.html)
DK (1) DK160805C (cg-RX-API-DMAC10.html)
GB (2) GB8311804D0 (cg-RX-API-DMAC10.html)
GR (1) GR81966B (cg-RX-API-DMAC10.html)
IE (1) IE57286B1 (cg-RX-API-DMAC10.html)
IL (1) IL71650A (cg-RX-API-DMAC10.html)
NZ (1) NZ207962A (cg-RX-API-DMAC10.html)
PT (1) PT78492B (cg-RX-API-DMAC10.html)
ZA (1) ZA843032B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209427D1 (de) * 1992-01-10 1998-08-27 Irina Alekseevna Komissarova Verwendung der aminosäure glycin zur herstellung von arzneimitteln mit antistress-, stressschutz- und nootroper wirkung
CN1303991C (zh) * 1998-05-15 2007-03-14 沃尼尔·朗伯公司 γ－氨基丁酸衍生物的稳定药物制剂和其制备方法
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6057368A (en) 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6713497B1 (en) * 2003-03-17 2004-03-30 Brookhaven Science Associates, Llc Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals
US20090017047A1 (en) * 2004-06-11 2009-01-15 Egon Tech Preparation for the Prevention and Treatment of Stress Conditions as Well as Functional and Organic Disorders of the Nervous System and Metabolic Disorders
CN101102759A (zh) * 2005-01-14 2008-01-09 欧加农股份有限公司 治疗药物和酒精依赖的甘氨酸再摄取抑制剂
US20160151316A1 (en) * 2012-01-27 2016-06-02 Catalyst Pharmaceutical Partners Method of treating tourette's disorder with gaba-aminotransferase inactivators
US10226442B2 (en) 2017-07-10 2019-03-12 Syneurx International (Taiwan) Corp. Lithium salts of N-substituted glycine compounds and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1111433A (en) * 1965-08-25 1968-04-24 Zoja Lab Chim Farm A method to potentiate the activity of a group of sedative,hypnotic and narcotic compositions
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
FR2437834A1 (fr) * 1978-10-04 1980-04-30 Lejeune Jerome Compositions pharmaceutiques a base de l-serine ou de glycine
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
NZ207962A (en) 1986-12-05
AU563291B2 (en) 1987-07-02
AU2644384A (en) 1984-11-01
GB2138680A (en) 1984-10-31
PT78492B (en) 1986-06-11
IE57286B1 (en) 1992-07-15
GB8311804D0 (en) 1983-06-02
EP0124091A2 (en) 1984-11-07
DK160805B (da) 1991-04-22
DK213484A (da) 1984-10-30
DK213484D0 (da) 1984-04-27
GB2138680B (en) 1986-05-21
IL71650A0 (en) 1984-07-31
IE841048L (en) 1984-10-29
ATE48759T1 (de) 1990-01-15
CA1228818A (en) 1987-11-03
EP0124091B1 (en) 1989-12-20
IL71650A (en) 1988-07-31
DK160805C (da) 1991-10-07
ZA843032B (en) 1984-11-28
GR81966B (cg-RX-API-DMAC10.html) 1984-12-12
JPS59206309A (ja) 1984-11-22
US4540582A (en) 1985-09-10
EP0124091A3 (en) 1987-10-07
JPH0527606B2 (cg-RX-API-DMAC10.html) 1993-04-21
GB8410504D0 (en) 1984-05-31
PT78492A (en) 1984-05-01

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE69427704D1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n-disubstituierte-amino-3,4-dihydro-2h-1-benzopyrane
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
ATE111303T1 (de) Synergistische mikrobizide kombinationen.
DE69435086D1 (de) Phenylacetate und Derivate, allein oder in Kombination mit anderen Verbindungen, zur Behandlung von neoplastischen und anderen Erkrankungen
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
DE3480764D1 (de) Behandlung von anfaellen und hierfuer nuetzliche pharmazeutische zusammensetzungen.
RU94031161A (ru) Фармацевтическая композиция и способ ее получения, способ лечения нарушений, развивающихся вследствие нейродегенеративных процессов
DE3480901D1 (de) Haarbehandlungsmittel.
ATE297722T1 (de) Verwendung von gaba analoga wie gabapentin zur herstellung eines medikaments für die behandlung von entzündungserkrankungen
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
ATE222768T1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
DE69905489D1 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
IT1237088B (it) N,n'-di-(trimetossibenzoil) piperazine 2-carbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
ATE57526T1 (de) P-acylaminobenzamide.
ATE6124T1 (de) Arzneimittel zur lokalen behandlung des glaukoms.
IT1237087B (it) N,n'-di-(trimetossibenzoil) piperazine 2-metossicarbonil sostituite, procedimento per preparare le stesse e composti terapeutici che le contengono.
ES2051788T3 (es) Un producto farmaceutico.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition